First description of a sporadic breast cancer in a woman with BRCA1 germline mutation-Reference-Cited by-同舟云学术

First description of a sporadic breast cancer in a woman with BRCA1 germline mutation

Published:2015-09-29 Issue:34 Volume:6 Page:35616-35624
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Curtit Elsa¹²³⁴⁵,Benhamo Vanessa⁶,Gruel Nadège⁷⁸,Popova Tatiana⁷,Manie Elodie⁷,Cottu Paul¹,Mariani Odette⁹,Stoppa-Lyonnet Dominique⁹,Pivot Xavier²³⁴,Stern Marc-Henri⁷,Vincent-Salomon Anne⁶⁹

Affiliation:

1. Department of Medical Oncology, Institut Curie, 75248 Paris, France

2. Department of Medical Oncology, University Hospital, 25000 Besançon, France

3. University of Franche-Comté, Medical Department, 25000 Besançon, France

4. INSERM U1098, Medical Oncology Department, 25000 Besançon, France

5. Present affiliations: 2-4; affiliation when working on this case: 1

6. Université Paris Sciences Lettres, Medical Department, INSERM U934, Institut Curie, 75248 Paris, France

7. Université Paris Sciences Lettres, Medical Department, INSERM U830, Institut Curie, 75248 Paris, France

8. Department of Translational Research, Institut Curie, 75248 Paris, France

9. Department of Pathology, Genetics and Immunology, Institut Curie, 75248 Paris, France

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of CSNK1D and KLK6 as two common upregulated genes present in BRCA1 mutated triple-negative breast cancer and ovarian epithelial carcinoma;Nucleosides, Nucleotides & Nucleic Acids;2024-05-23

2. Prognostic and Predictive Biomarkers in Familial Breast Cancer;Cancers;2023-02-20

3. Prognostic significance of germline BRCA mutations in patients with HER2-POSITIVE breast cancer;The Breast;2022-10

4. Case Report Series: Aggressive HR Deficient Colorectal Cancers Related to BRCA1 Pathogenic Germline Variants;Frontiers in Oncology;2022-02-24

5. Value of the loss of heterozygosity to BRCA1 variant classification;npj Breast Cancer;2022-01-17